Polomar Health Services, Inc. has announced that its Audit Committee has determined that certain previously issued financial statements should no longer be relied upon. This decision stems from accounting errors identified in the company’s financial reporting for the periods ending March 31, 2026, and June 30, 2026. The implications of this announcement are significant for the company and its stakeholders, as it highlights the critical need for accurate financial disclosures in the pharmaceutical preparations industry.
The company’s decision to restate its financial reports comes after management identified issues related to the accounting for commission expenses, inventory purchases, interest expenses, revenue recognition, and misclassification of equity. As a result, Polomar Health Services expects to increase its net loss by approximately $421,000 for the affected periods. This includes an estimated increase of $332,000 for the first quarter of 2026 and $89,000 for the second quarter of 2026.
Background
Polomar Health Services, Inc. operates within the pharmaceutical preparations sector, classified under SIC 2834. The company, which trades under the ticker PMHS on the OTC exchange, is based in Palm Harbor, Florida. It has undergone several name changes in recent years, with its most recent name change occurring in May 2023, when it transitioned from Trustfeed Corp.
What the Filing Says
According to the recent SEC filing dated November 3, 2026, the Audit Committee concluded that the company’s unaudited condensed consolidated financial statements for specific periods should no longer be relied upon. The filing states, "These periods are collectively referred to as the 'Non-Reliance Periods.'" The company plans to amend its Quarterly Reports on Form 10-Q to reflect these changes.
Impact
This announcement may have a wide-ranging impact on various stakeholders, including investors, employees, and auditors. Investors are particularly cautioned against relying on previous financial communications, as the company reassesses its internal controls and procedures. The identified errors could affect the company’s credibility and financial stability, potentially influencing investor confidence.
What's Next
Polomar Health Services intends to file amendments to its affected Quarterly Reports on Form 10-Q/A as soon as practicable. Management is also expected to report one or more material weaknesses in its internal controls over financial reporting, which will be disclosed in future filings. The filing does not specify an exact timeline for these amendments.
Read Next
Ashland Inc. announces preliminary Q4 and FY 2026 results
Curaleaf Holdings reports strong Q3 results, boosts outlook
Syra Health Corp reports Q3 results, shows revenue growth
Dominion Energy, NextEra Enhance Merger Proposal with Protections
Fairfax Financial reports Q3 earnings decline amid market shifts
Aldel Financial II Inc. Reports Q3 2026 Results










